IFG Advisory’s RxSight RXST Stock Holding History

IFG Advisory’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472	Buy	+98	New	+$592	﹤0.01%	2250

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IFG Advisory's RXST Position: Q2 2026 in Review

IFG Advisory opened a new position in RxSight (RXST) in Q2 2026: 98 shares worth $472. The stake represents ﹤0.01% of the portfolio and ranks #2250 among its holdings.

152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

IFG Advisory held 98 shares of RxSight worth $472 as of Q2 2026.
RxSight was a new IFG Advisory position in Q2 2026.
RxSight made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #2250 holding.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.